Learn more about whether Recursion Pharmaceuticals, Inc. or Syndax Pharmaceuticals, Inc. is a better investment based on AAII ...

Recursion Pharmaceuticals has been trying to rebuild momentum after a steep five year decline in shareholder returns, yet its ...

Recursion harnesses AI for large-scale drug discovery, while Summit's betting on a single oncology candidate. How do their ...

These days, the frontier AI labs are all racing to build self-improving models. Some believe it’s the surest route to ...

These aren't for the faint of heart.

Recursive self-improvement AI now has a co-evolving evaluator: a Cambridge and NVIDIA preprint introduces the Red Queen Gödel ...

AI isn't failing because models are bad; it's struggling because most industries lack the structured workflows needed to ...

For the past decade, we’ve been sold a seductive vision: the “smart city.” Gleaming control rooms, traffic lights that talk ...

Governments currently lack the frameworks, technical expertise, and speed to evaluate and regulate such advanced AI. The ...

The latest generation of AI models are such competent coders, engineers and (soon) scientists that many worry they may be ...

Covering more ground faster creates better outcomes only if you know which direction to run. Over the course of my career, ...

See what other data-removal sites miss with Optery's free full Exposure Report that shows exactly where your information ...